ARTICLE | Company News
metaGen, RNAx target deal
March 25, 2003 8:00 AM UTC
Functional genomics company RNAx (Berlin, Germany) granted metaGen (Berlin, Germany) access to its RNA interference (RNAi) validation technology. metaGen will use the technology to validate cancer gen...